Assessment on the Deep Remission Rate and Its Influencing Factors of Individualized Ustekinumab Therapy in Patients With Crohn's Disease
Clinical trial NCT07600255 · COMPLETED
Trial details
- NCT number
- NCT07600255
- Sponsor
- Second Affiliated Hospital of Wenzhou Medical University
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2021-01-01
- Primary completion
- 2026-01-01
- Enrollment
- 156
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.